drugset / Trial / NCT01162824

Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries

NCT01162824

Unknown 50 enrolled St George's Healthcare NHS Trust
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The investigators are hoping to discover the cause of chest pain in patients with a normal coronary arteriogram. For patients with chest pain coronary angiography is the standard method by which the blood vessels of the heart can be visualized and any narrowing can be assessed. In some cases the investigators find totally normal coronary blood vessels or only minor disease. Such a finding is associated with an excellent long term prognosis. However, as a large proportion of patients with normal coronary arteries or mild coronary narrowings often continue to experience recurrent chest pains the investigators are interested in understanding the mechanisms responsible for this. The investigators hypothesise that in many cases, coronary artery spasms are responsible for the recurrent chest pains. These spasms usually respond to treatment with drugs known as vasodilators. The acetylcholine test (ACH-test) has been recommended by the European Society of Cardiology and the American College of Cardiology as a diagnostic test. This test can reveal whether the coronary blood vessels have a tendency to go into spasm. The investigators plan in this study to carry out the test in patients who have chest pains suggestive of coronary narrowings but are found to have normal or only mildly narrowed coronary arteries on angiography. A positive test -indicating a tendency for spasm- may help guiding therapy with vasodilators, which are often very effective to prevent coronary spasms. The investigators would also like to take blood samples during the test (before and after) from every patient to measure blood markers and see if there is a relation between these markers and the result of the ACH-test.

Timeline

Start
2011-01
Primary completion
2011-04
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcholine Small molecule 2 ug Other
Subject Acetylcholine Small molecule 20 ug Other
Subject Acetylcholine Small molecule 80 ug Other
Subject Acetylcholine Small molecule 100 ug Other
Subject Adenosine Small molecule 140 ug/kg Intravenous
Subject Adenosine Small molecule 180 ug/kg Intravenous